Si Bone Net Worth
Si Bone Net Worth Breakdown | SIBN |
Si Bone Net Worth Analysis
Si Bone's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Si Bone's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Si Bone's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Si Bone's net worth analysis. One common approach is to calculate Si Bone's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Si Bone's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Si Bone's net worth. This approach calculates the present value of Si Bone's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Si Bone's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Si Bone's net worth. This involves comparing Si Bone's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Si Bone's net worth relative to its peers.
Enterprise Value |
|
To determine if Si Bone is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Si Bone's net worth research are outlined below:
| Si Bone generated a negative expected return over the last 90 days | |
| Si Bone has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 138.89 M. Net Loss for the year was (43.34 M) with profit before overhead, payroll, taxes, and interest of 90.7 M. | |
| Si Bone currently holds about 114.41 M in cash with (18.71 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.34. | |
| Over 98.0% of the company shares are owned by institutional investors | |
| Latest headline from thelincolnianonline.com: Jeffrey W. Dunn Sells 1,609 Shares of SI-BONE, Inc. Stock |
Si Bone uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Si Bone. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Si Bone's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 26th of February 2024 Upcoming Quarterly Report | View | |
| 6th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 26th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know Si Bone's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Si Bone is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Si Bone backward and forwards among themselves. Si Bone's institutional investor refers to the entity that pools money to purchase Si Bone's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | State Street Corp | 2024-06-30 | 1 M | Wellington Management Company Llp | 2024-06-30 | 993 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 989.4 K | Geode Capital Management, Llc | 2024-09-30 | 924 K | Nuveen Asset Management, Llc | 2024-06-30 | 871.3 K | Next Century Growth Investors Llc | 2024-06-30 | 845.4 K | Kent Lake Capital Llc | 2024-06-30 | 800 K | Holocene Advisors, Lp | 2024-09-30 | 585.3 K | Impax Asset Management Group Plc | 2024-06-30 | 536.9 K | Brown Advisory Holdings Inc | 2024-09-30 | 4 M | Blackrock Inc | 2024-06-30 | 3.8 M |
Follow Si Bone's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 530.52 M.Market Cap |
|
Project Si Bone's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.19) | (0.20) | |
| Return On Capital Employed | (0.23) | (0.24) | |
| Return On Assets | (0.19) | (0.20) | |
| Return On Equity | (0.26) | (0.27) |
When accessing Si Bone's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Si Bone's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Si Bone's profitability and make more informed investment decisions.
Evaluate Si Bone's management efficiency
Si Bone has return on total asset (ROA) of (0.1154) % which means that it has lost $0.1154 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2209) %, meaning that it created substantial loss on money invested by shareholders. Si Bone's management efficiency ratios could be used to measure how well Si Bone manages its routine affairs as well as how well it operates its assets and liabilities. As of the 26th of November 2024, Return On Tangible Assets is likely to drop to -0.2. In addition to that, Return On Capital Employed is likely to drop to -0.24. At this time, Si Bone's Asset Turnover is very stable compared to the past year.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 4.41 | 4.63 | |
| Tangible Book Value Per Share | 4.41 | 4.63 | |
| Enterprise Value Over EBITDA | (23.58) | (24.76) | |
| Price Book Value Ratio | 4.76 | 4.52 | |
| Enterprise Value Multiple | (23.58) | (24.76) | |
| Price Fair Value | 4.76 | 4.52 | |
| Enterprise Value | 812.3 M | 852.9 M |
Si Bone's management has consistently demonstrated strong leadership, driving both financial growth and operational excellence. By analyzing current market trends and future growth opportunities, we assess the stock's true value and potential for investors.
Enterprise Value Revenue 2.6633 | Revenue 157 M | Quarterly Revenue Growth 0.186 | Revenue Per Share 3.817 | Return On Equity (0.22) |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Si Bone insiders, such as employees or executives, is commonly permitted as long as it does not rely on Si Bone's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Si Bone insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Si Bone Corporate Filings
F4 | 20th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
13A | 14th of November 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
| 12th of November 2024 Other Reports | ViewVerify | |
F3 | 7th of August 2024 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
Si Bone Earnings per Share Projection vs Actual
Si Bone Corporate Management
| Anshul Maheshwari | Chief Officer | Profile | |
| Aimee Einstein | Vice Culture | Profile | |
| Daniel Cher | Senior Affairs | Profile | |
| Michael Pisetsky | General Counsel and Chief Compliance Officer | Profile | |
| Laura MBA | CEO Director | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Si Bone. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. To learn how to invest in SIBN Stock, please use our How to Invest in Si Bone guide.You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Si Bone. If investors know SIBN will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Si Bone listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.92) | Revenue Per Share 3.817 | Quarterly Revenue Growth 0.186 | Return On Assets (0.12) | Return On Equity (0.22) |
The market value of Si Bone is measured differently than its book value, which is the value of SIBN that is recorded on the company's balance sheet. Investors also form their own opinion of Si Bone's value that differs from its market value or its book value, called intrinsic value, which is Si Bone's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Si Bone's market value can be influenced by many factors that don't directly affect Si Bone's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Si Bone's value and its price as these two are different measures arrived at by different means. Investors typically determine if Si Bone is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Si Bone's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.